European Union Considering Letting Gilead Sell Remdesivir

By Ariel Cohen / May 21, 2020 at 12:06 PM
The European Union is considering letting Gilead sell remdesivir while the antiviral is studied as a COVID-19 treatment. By allowing sales of the drug, the European Union would make the drug more widely available than in the United States. Remdesivir is not approved for any condition by the FDA, but it has shown some promise as a treatment for COVID-19. The FDA in May allowed emergency use of the drug for hospitalized patients with severe COVID-19 , but emergency use...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.